Skip to main content

Market Overview

Why Lexicon Pharma's Stock Is Surging Higher Today

Share:
Why Lexicon Pharma's Stock Is Surging Higher Today

Lexicon Pharmaceuticals (NASDAQ: LXRX) shares are trading sharply higher after the company announced it received FDA regulatory feedback that the results of its SOLOIST and SCORED Phase 3 clinical studies can support a new drug application submission.

Lexicon is a biopharmaceutical company developing medicines that transform patients' lives. The company commercializes and develops drugs and drug candidates.

Lexicon's stock was trading higher by 102% to $7.92 at the time of publciaiton.

 

Related Articles (LXRX)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Small Cap Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com